A clutch of trading updates and results dominated Tuesday's premarket agenda, with Marston's (LSE:MARS), Greggs (LSE:GRG), and Wickes (LSE:WIX) all reaffirming full-year guidance, while Angling Direct (AIM:ANG) went further and upgraded its medium-term outlook after crossing the £100m revenue threshold for the first time. Novo Nordisk (NYSE:NVO) added fresh clinical weight-loss data to the mix, and Wizz Air (LSE:WIZZ) closed out its financial year ahead of prior guidance.
Marston's holds full-year guidance as H1 margins improve
Marston's (LSE:MARS) reaffirmed it remains on track to meet full-year market expectations for FY2026, reporting underlying profit before tax of £20.5m for the first half alongside underlying EBITDA of £85.9m, maintained year-on-year, with margins moving higher across the period. Chief executive Justin Platt pointed to the operational progress underpinning the result as the pub chain continues its managed estate strategy.
Angling Direct crosses £100m revenue mark and lifts medium-term targets
Angling Direct (AIM:ANG) upgraded its medium-term financial objectives after reporting record group revenue of £103.9m for the year to 31 January, a rise of 13.8% year-on-year. The fishing retailer's chief executive Steve Crowe said the milestone validated the group's multichannel growth model, with the upgraded targets reflecting greater confidence in the trajectory of both domestic and European operations.
Greggs lifts total sales 7.5% in first 19 weeks while holding outlook steady
Greggs (LSE:GRG) reported total sales of £800m for the first 19 weeks of 2026, up 7.5%, with like-for-like sales also improving compared with the prior year. The bakery chain left its full-year expectations unchanged, signalling that the board sees the trading momentum as consistent with, rather than ahead of, its existing plan.
Wickes posts early revenue growth and reiterates profit consensus comfort
Wickes Group (LSE:WIX) reported revenue growth of 1.3% in the 17 weeks to 25 April and said it remains comfortable with consensus expectations for adjusted profit before tax for the full year. The home improvement retailer's update, delivered by chief executive David Wood, was enough to nudge the shares 0.7% higher to 219.0p in early dealing.
Novo Nordisk data shows 27.7% weight loss in early Wegovy responders at 72 weeks
Novo Nordisk (CPH:NOVO B) presented a STEP UP sub-analysis at the European Congress on Obesity showing that patients who achieved weight loss of ≥15% by week 24 on semaglutide 7.2 mg went on to lose an average of 27.7% of body weight by week 72. A separate analysis from the same dataset found that the majority of weight lost comprised fat mass rather than lean muscle, a finding the company's team, including Emil Kongshøj Larsen, highlighted as clinically meaningful for the obesity treatment profile of the higher-dose formulation.
Wizz Air guides to breakeven or better as full-year revenue outperforms
Wizz Air (LSE:WIZZ) said it expects a breakeven to slightly positive net profit for the year ended 31 March, an outcome ahead of its previous guidance, after stronger revenue performance and a well-hedged cost position across fuel and currency. Chief executive Jozsef Varadi attributed the improvement to disciplined capacity management and the airline's macro hedging strategy. The shares eased 1.1% to 896.5p in early trade, suggesting the market had already priced in a degree of recovery.
